Virucidal efficacy of povidone-iodine-containing disinfectants

Letters in Applied Microbiology

Volumn 51, Issue 2, 2010, Pages 158-163

  Sauerbrei, A ^a   Wutzler, P ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Betaisodona ; Betaseptic Mundipharma ; German guideline for virucidal testing of biocides; povidone iodine; virucidal efficacy

Indexed keywords

BIOCIDES; INDUSTRIAL CHEMICALS; VIRUSES;

GERMAN GUIDELINE FOR VIRUCIDAL TESTING OF BIOCIDES; HUMAN VIRUS; ORGANIC LOAD; POLIOVIRUS; POLYOMAVIRUS; SHORT TIME INTERVALS; SUSPENSION TEST; TIME INTERVAL; VACCINIA VIRUS;

IODINE;

BETASEPTIC MUNDIPHARMA; POVIDONE IODINE; UNCLASSIFIED DRUG; DISINFECTANT AGENT;

DISINFECTION; IODINE; NUMERICAL MODEL; PESTICIDE; PROTEIN; QUANTITATIVE ANALYSIS; SPECIES DIVERSITY; VIRULENCE; VIRUS;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; NONHUMAN; POLIOMYELITIS VIRUS 1; QUANTITATIVE ANALYSIS; SIMIAN VIRUS 40; VACCINIA VIRUS; ANIMAL; CELL LINE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; TIME; VIRUS; VIRUS LOAD;

ANIMALS; CELL LINE; DISINFECTANTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; POVIDONE-IODINE; TIME FACTORS; VIRAL LOAD; VIRUSES;

EID: 77954529710     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2010.02871.x     Document Type: Article

References (33)

1. Ali, Y., Dolan, M.J., Fendler, E.J. Larson, E.L. (2001) Alcohols. In Disinfection, Sterilisation, and Preservation, 5th edn ed. Block, S.S. pp. 229 253.
2. Anon. (2009) Guideline of "Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V." (DVV; German Association for the Control of Virus Diseases) and Robert Koch Institute (RKI; German Federal Health Authority) for testing the virucidal efficacy of chemical disinfectants in the human medical area. Hyg Med 34, 293 299.
3. Bhattacharjee, B., Varshney, A. Bhat, S.N. (1983) Kinetics of transformation of outer charge-transfer complexes to inner complexes. J Ind Chem Soc 60, 842 844.
4. Bialasiewicz, A.A. (2002) Therapeutic indications for local anti-infectives. In Antiseptic Prophylaxis and Therapy in Ocular Infections ed. Kramer, A. Behrens-Baumann, W. Developments in Ophthalmology 33, pp. 243 249.
5. Block, S.S. (2001) Peroxygen compounds. In Disinfection, Sterilisation, and Preservation, 5th edn ed. Block, S.S. pp. 185 204.
6. Darouiche, R.O., Wall, M.J. Jr., Itani, K.M., Otterson, M.F., Webb, A.L., Carrick, M.M., Miller, H.J., Awad, S.S. et al. (2010) Chorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362, 18 26.
7. Durani, P. Leaper, D. (2008) Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J 5, 376 387.
8. European Committee for Standardisation (2005) Chemical disinfectants and antiseptics - Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine - Test method and requirements (phase 2, step 1); German version EN 14476:2005/prA1:2006.
9. Görtz, G., Reimer, K. Neef, H. (1996) Eigenschaften und Bedeutung von PVP-I. In Topische Infektionstherapie und Prophylaxe ed. Hierholzer, G., Reimer, K. Weissenbacher, E.R. pp. 3 7.
10. Jarvis, W.R. (2007) The Lowbory Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. J Hosp Infect 65 (Suppl 2 3 9.
11. Jülich, W.D., von Rheinbaben, F., Steinmann, J. Kramer, A. (1993) On the virucidal efficacy of chemical and physical disinfectants or disinfection procedures. Hyg Med 18, 303 326.
12. König, B., Reimer, K., Fleischer, W. König, W. (1997) Effects of Betaisodona on parameters of host defense. Dermatology 195 (Suppl 2 42 48.
13. Kramer, A. Rudolph, P. (2002) Efficacy and tolerance of selected antiseptic substances in respect of suitability for use on the eye. In Antiseptic Prophylaxis and Therapy in Ocular Infections ed. Kramer, A. Behrens-Baumann, W. Developments in Ophthalmology 33, pp. 117 144.
14. Kramer, A., Below, H., Behrens-Baumann, W., Müller, G., Rudolph, P. Reimer, K. (2002) New aspects of the tolerance of the antiseptic povidone-iodine in different ex vivo models. Dermatology 204 (Suppl 1 86 91.
15. Lages, S.J.S., Ramakrishnan, M.A.A. Goyal, S.M. (2008) In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus. J Hosp Infect 68, 159 163.
16. Nishimura, C. (2006) Comparison of the antimicrobial efficacy of povidone-iodine, povidone-iodine-ethanol and chlorhexidine gluconate-ethanol surgical scrubs. Dermatology 212, 21 25.
17. Nobukuni, K. Kawahara, S. (2002) Thyroid function in nurses: the influence of povidone-iodine hand washing and gargling. Dermatology 204 (Suppl 1 99 102.
18. Reimer, K., Fleischer, W., Brögmann, B., Schreier, H., Burkhard, P., Lanzendörfer, A., Gümbel, H., Hoekstra, H. et al. (1997) Povidone-iodine liposomes - an overview. Dermatology 195 (Suppl 2 93 99.
19. Reimer, K., Vogt, P.M., Broegmann, B., Hauser, J., Rossbach, O., Kramer, A., Rudolph, P., Bosse, B. et al. (2000) An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel. Dermatology 201, 235 241.
20. Reimer, K., Wichelhaus, T.A., Schäfer, V., Rudolph, P., Kramer, A., Wutzler, P., Ganzer, D. Fleischer, W. (2002) Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology 204 (Suppl 1 114 120.
21. Robert Koch-Institut (2007) Liste der vom Robert-Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 10, 1353 1356.
22. Sattar, S.A. (2004) Microbicides and the environmental control of nosocomial infections. J Hosp Infect 56 (Suppl 2 S64 S69.
23. Sauerbrei, A., Sehr, K., Brandstädt, A., Heim, A., Reimer, K. Wutzler, P. (2004) Sensitivity of human adenoviruses to different groups of chemical biocides. J Hosp Infect 57, 59 66.
24. Sauerbrei, A., Eschrich, W., Brandstädt, A. Wutzler, P. (2009) Sensitivity of poliovirus type 1 and ECHO virus type 1 to different groups of chemical biocides. J Hosp Infect 72, 277 279.
25. Schreier, H., Erdos, G., Reimer, K., König, B., König, W. Fleischer, W. (1997) Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology 195 (Suppl 2 111 116.
26. Sporkenbach, I. (1980) Über die fehlende inaktivierende Wirkung einiger PVP-Jod-Verbindungen gegenüber Poliomyelitis- und Adenoviren. Hyg Med 5, 357 362.
27. Steinmann, J. (2004) Surrogate viruses for testing virucidal efficacy of chemical disinfectants. J Hosp Infect 56, S49 S54.
28. Suwanpimolkul, G., Pongkumpai, M. Suankratay, C. (2008) A randomized trial of 2% chlorhexidine tincture compared with 10% aqueous povidone-iodine for venipuncture site disinfection: effects on blood culture contamination rates. J Infect 56, 354 359.
29. Velázquez, D., Zamberk, P., Suárez, R. Lázaro, P. (2009) Allergic contact dermatitis to povidone-iodine. Contact Dermatitis 60, 348 349.
30. Wright, S.A. Bieluch, V.M. (1993) Selected nosocomial viral infections. Heart Lung 22, 183 187.
31. Wutzler, P. Sauerbrei, A. (2000) Virucidal efficacy of a combination of 0.2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant. J Hosp Infect 46, 304 308.
32. Wutzler, P. Sauerbrei, A. (2004) Virucidal activity of the new disinfectant monopercitric acid. Lett Appl Microbiol 39, 194 198.
33. Wutzler, P., Sauerbrei, A., Klöcking, R., Brögmann, B. Reimer, K. (2002) Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res 54, 89 97.